Categories
Cardiovascular
Diagnostics
Endocrinology
Health Insurance
Medical Devices
Mental Health
Nutrition
Oncology
Public Health
Sexual Health
Popular Articles

Scientists Slowed Growth Of Ovarian Tumors In Mice Using Nanoparticles To Deliver Suicide Genes
Scientists in the US have found a way of slowing the growth of ovarian cancer tumors in mice by using nanoparticles to deliver suicide genes to

Consumers Making Effort To Buy Healthy Foods But Buyer Beware: "Zero" Isn't Always Zero
Americans trying to eat healthier are looking to nutrition labels to help make better choices at the grocery store. But consumers who take those labels at face value may find they"re not eating as healthy as they think.
News of the day
Nursing Shortage Eases With Recession's Help
"The nation"s deep recession is helping to alleviate the decade-long nursing shortage, as workers who had left the field in better times are returning in droves," the Wall Street Journal reports. The paper quotes a study, one of six papers on the nursing workforce published today in the journal Health Affairs, that found "nearly a quarter-million nurses entered the work force in 2007-08, an 18% surge that was the largest two-year increase in at least three decades." Many of them had left nursing, but "re-entered the work force to compensate for a spouse"s lost income or health benefits, the study said." The increase is "particularly remarkable at a time when the U.S. economy has shed more than six million jobs, helping to solidify the profession"s "recession-proof" image." The study found that the surge in new nurses is due to "efforts to expand nursing schools, attract more young people into the field and improve working conditions," along with an increase in the number of foreign-born nurses.
Endocrinology

AVI BioPharma, Inc. Presents At American Society Of Virology Annual Meeting

AVI BioPharma, Inc. (NASDAQ: AVII), a developer of RNA-based drugs, today announced that Dr. Fred Schnell of AVI presented at the American Society of Virology Annual Meeting which took place July 11-15 in Vancouver, B.C. The title of the presentation was "Pan-Arenavirus Antisense Therapeutic Based On PMOplus™ Chemistry." In addition to Dr. Schnell, Drs. Bestwick, Iversen and Mourich, all of AVI, coauthored the presentation. Schnell presented results of preclinical findings using an antiviral oligomer compound that incorporates AVI"s proprietary backbone chemistry (PMOplus™). The work shows that a single oligomer blocks a terminal sequence common to the eight distinct RNAs expressed by viruses from the family of hemorrhagic fever arenaviruses. Because this sequence is highly conserved among arenaviruses, a single agent might serve as a pan-arenavirus drug. Arenaviruses include Lassa fever, lymphocytic choriomeningitis, Junin and Machupo viruses, all members of the Class A bioterrorism pathogen list. "We believe that the PMOplus™ chemistry is particularly useful for targeting potential variable or mutation prone sequences within the viral RNA," said Ryszard Kole, AVI Senior V.P. Discovery Research. "This chemistry, combined with the fact that a single agent blocks RNAs involved in several steps of the viral life cycle of a whole family of viruses, makes this approach to viral drug discovery look very promising." AVI BioPharma


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):

© Copyright 2009